Faculty

Andy Stergachis

Adjunct Professor, Epidemiology
Professor, Pharmacy
Professor, Global Health
Adjunct Professor, Health Metrics Sciences
Adjunct Professor, Health Systems and Population Health
Associate Dean, School of Pharmacy

206-221-0703
stergach@uw.edu

Education

PhD Pharmacy, University of Minnesota, 1979
MS Pharmacy, University of Minnesota, 1976
BPharm Pharmacy, Washington State University, 1975

Contact

206-221-0703
stergach@uw.edu

Office H-362B, Health Sciences Building
Box 357631
WA

Research Interests

Dr. Stergachis' research focus is pharmacoepidemiology, global drugs and vaccine safety, pharmaceutical outcomes research, and public health systems research. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries. He is one of very few pharmacists ever elected to the National Academy of Medicine. His research has been supported, in part, by the Bill and Melinda Gates Foundation, USAID, the Barr Foundation, the Partnership for Quality Medical Donations, and USP. He is a Fellow of the International Society for Pharmacoepidemiology, Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, Chair of the Low-dose Primaquine Safety Study Group for the WorldWide Antimalarial Resistance Network and member of the Access and Product Management Advisory Committee for Medicines for Malaria Venture. He has conducted pharmacovigilance trainings and related pharmaceutical systems strengthening activities in numerous low- and middle-income countries (e.g., Namibia, Vietnam, Rwanda, Ethiopia, Zimbabwe, China, India, Kenya, Bangladesh, Eritrea, Philippines, Uganda, and Ukraine). Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community.

Recent Publications (PubMed)

Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
(2022 Nov 25)
Lancet
Saito M, McGready R, Tinto H, Rouamba T, Mosha D, Rulisa S, Kariuki S, Desai M, Manyando C, Njunju EM, Sevene E, Vala A, Augusto O, Clerk C, Were E, Mrema S, Kisinza W, Byamugisha J, Kagawa M, Singlovic J, Yore M, van Eijk AM, Mehta U, Stergachis A, Hill J, Stepniewska K, Gomes M, Guérin PJ, Nosten F, Ter Kuile FO, Dellicour S

The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
(2022 Oct)
J Int AIDS Soc 25(10): e26027
Kuo AP, Roche SD, Mugambi ML, Pintye J, Baeten JM, Bukusi E, Ngure K, Stergachis A, Ortblad KF

Pharmacy deserts and COVID-19 risk at the census tract level in the State of Washington.
(2022 Dec)
Vaccine X 12(): 100227
Wittenauer R, Shah PD, Bacci JL, Stergachis A

Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data.
(2022 Sep 16)
BMC Med 20(1): 350
Stepniewska K, Allen EN, Humphreys GS, Poirot E, Craig E, Kennon K, Yilma D, Bousema T, Guerin PJ, White NJ, Price RN, Raman J, Martensson A, Mwaiswelo RO, Bancone G, Bastiaens GJH, Bjorkman A, Brown JM, D'Alessandro U, Dicko AA, El-Sayed B, Elzaki SE, Eziefula AC, Gonçalves BP, Hamid MMA, Kaneko A, Kariuki S, Khan W, Kwambai TK, Ley B, Ngasala BE, Nosten F, Okebe J, Samuels AM, Smit MR, Stone WJR, Sutanto I, Ter Kuile F, Tine RC, Tiono AB, Drakeley CJ, Gosling R, Stergachis A, Barnes KI, Chen I

Preparing for Disease X: Ensuring Vaccine Equity for Pregnant Women in Future Pandemics.
(2022)
Front Med (Lausanne) 9(): 893292
Munoz FM, Cutland CL, Jones CE, Kampmann B, Khalil A, Sevene E, Stergachis A, Swamy GK, Voss G, Sobanjo-Ter Meulen A

Show complete publication list